Borrelia burgdorferi P35 and P37 Proteins, Expressed In Vivo, Elicit Protective Immunity
Open Access
- 1 May 1997
- Vol. 6 (5) , 531-539
- https://doi.org/10.1016/s1074-7613(00)80341-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Serodiagnosis of Lyme Disease: Accuracy of a Two-Step Approach Using a Flagella-Based ELISA and ImmunoblottingThe Journal of Infectious Diseases, 1996
- Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.The Journal of Experimental Medicine, 1996
- Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.The Journal of Experimental Medicine, 1996
- Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologueMolecular Microbiology, 1995
- Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.Journal of Clinical Investigation, 1995
- Early and specific antibody response to OspA in Lyme Disease.Journal of Clinical Investigation, 1994
- Western Blotting in the Serodiagnosis of Lyme DiseaseThe Journal of Infectious Diseases, 1993
- Serologic Diagnosis of Lyme Disease using Recombinant Outer Surface Proteins A and Band FlagellinThe Journal of Infectious Diseases, 1992
- Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.The Journal of Experimental Medicine, 1991
- Protection of Mice Against the Lyme Disease Agent by Immunizing with Recombinant OspAScience, 1990